Skip to main content
. 2018 Dec 3;11:8623–8632. doi: 10.2147/OTT.S181413

Figure 3.

Figure 3

Forest plots for OS, PFS, and ORR for PD1/PDL1 blockades vs docetaxel.

Note: *Represents data in this article that compares different doses of Pembrolizumab with docetaxel.

Abbreviations: OS, overall survival; PFS, progression-free survival; ORR, overall response rate.